Cargando…

Regulation of cognitive enhancement devices: commentary

Maslen et al. (2013) have provided us with a comprehensive overview of the current legislation regulating non-clinical cognitive enhancement devices (CEDs) in the European Union and have proposed a specific model whereby CEDs would be regulated in the same way as medical devices. An alternative mode...

Descripción completa

Detalles Bibliográficos
Autores principales:	Johnson, Reuben, Gillett, Grant, Snelling, Jeanne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2014
Materias:	Peer Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5033528/ https://www.ncbi.nlm.nih.gov/pubmed/27774172 http://dx.doi.org/10.1093/jlb/lsu017

Ejemplares similares

The brain, cognitive enhancement devices, and European regulation
por: Kuersten, Andreas, et al.
Publicado: (2014)

Medical regulation of cognitive enhancement devices: some concerns
por: King, Mike, et al.
Publicado: (2014)

Outstanding questions concerning the regulation of cognitive enhancement devices
por: De Ridder, Dirk, et al.
Publicado: (2014)

Buttressing regulation of cognitive enhancement devices with principles of harm reduction
por: Fitz, Nicholas S., et al.
Publicado: (2014)

Commentary: Is there a problem Consent in Escrow can solve?
por: Taylor, Holly A.
Publicado: (2015)

Peer commentary: in vitro gametogenesis: just another way to have a baby
por: Carbone, June
Publicado: (2016)

Yesterday's war; tomorrow's technology: peer commentary on ‘Ethical, legal, social and policy issues in the use of genomic technologies by the US military’
por: Evans, Nicholas G., et al.
Publicado: (2014)

FDA's pathway for regulation of FMT: not so fraught
por: Riley, Margaret F., et al.
Publicado: (2015)

Precision medicine: a matter of regulation or collaboration?
por: Knoppers, Bartha Maria
Publicado: (2016)

Two kinds of rule regulating human subjects research
por: Sachs, Benjamin
Publicado: (2015)

Modernizing biomedical regulation: foresight and values in the promotion of responsible research and innovation
por: Harmon, Shawn H.E.
Publicado: (2016)

Regulating drug promotion to promote the public health: a response to Bennett et al.
por: Zettler, Patricia J.
Publicado: (2015)

Open peer review commentary on building clinically relevant outcomes across the Alzheimer's disease spectrum
por: Rockwood, Kenneth
Publicado: (2021)

Meaningful benefit and minimal clinically important difference (MCID) in Alzheimer's disease: Open peer commentary
por: Cummings, Jeffrey
Publicado: (2023)

Open peer commentary on “Prescribing anti‐amyloid immunotherapies to treat Alzheimer's disease: Fully informing patient decisions”
por: Gandy, Sam
Publicado: (2023)

Environmental neuroethics: changing the environment—changing the brain Recommendations submitted to the Presidential Commission for the Study of Bioethical Issues
por: Illes, Judy, et al.
Publicado: (2014)

Law and neuroscience: recommendations submitted to the President's Bioethics Commission
por: Jones, Owen D., et al.
Publicado: (2014)

Letter
Publicado: (2014)

Ethical considerations of neuroscience research and the application of neuroscience research findings for the Presidential Commission for the Study of Bioethical Issues
Publicado: (2014)

Considering advances in neuroscience through the lenses of law and human rights
por: Frankel, Mark S.
Publicado: (2014)

Military genomic testing: proportionality, expected benefits, and the connection between genotypes and phenotypes
por: Pence, Charles H.
Publicado: (2014)

Science wars—How much risk should soldiers be exposed to in military experimentation?
por: Savulescu, Julian
Publicado: (2015)

Dehumanization: its operations and its origins
por: Simpson, Robert Mark
Publicado: (2015)

Orphan drug incentives in the pharmacogenomic context: policy responses in the USA and Canada
por: Herder, Matthew
Publicado: (2016)

Hate speech, volition, and neurology
por: Roginsky, Alexandra B., et al.
Publicado: (2015)

Neuroscience cannot answer these questions: a response to G. and R. Murrow's essay hypothesizing a link between dehumanization, human rights abuses and public policy
por: Hoffman, Morris B.
Publicado: (2015)

Egg freezing, stratified reproduction and the logic of not
por: Ikemoto, Lisa C.
Publicado: (2015)

‘Good soldiers are made, not born’(⊥): the dangers of medicalizing ability in the military use of genetics
por: Roberts, Jessica L.
Publicado: (2015)

The most plausible pro-coercion view: requiring informed agreement while penalizing non-participation in research
por: Barnhill, Anne
Publicado: (2015)

Informed consent to participation in interventional studies: second-order in a different sense
por: Eyal, Nir
Publicado: (2015)

Are ethics promulgations self-defeating?
por: Gray, Derrick
Publicado: (2015)

Diversion effects, incentive effects, and the goals of research ethics promulgations
por: Wenner, Danielle M.
Publicado: (2015)

The problems of liminal states, line drawing, and false dichotomies
por: Suter, Sonia
Publicado: (2015)

The patent law Duchy of Grand Fenwick: a comment on The mouse that trolled: the long and tortuous history of a gene mutation patent that became an expensive impediment to Alzheimer's research
por: Sarnoff, Joshua D.
Publicado: (2015)

Off-label drug promotion and the ephemeral line between marketing and education
por: Krause, Joan H.
Publicado: (2015)

The mouse that trolled
por: Hardy, John
Publicado: (2015)

Universities and Patent Demands
por: Cordova, Andrew K., et al.
Publicado: (2015)

It depends whose data are being shared: considerations for genomic data sharing policies
por: Robinson, Jill O., et al.
Publicado: (2015)

A problem not yet manifest: gaps in insurance coverage of medical interventions after genetic testing
por: Malanga, Sarah, et al.
Publicado: (2015)

What do experimental simulations tell us about the effect of neuro/genetic evidence on jurors?
por: Scurich, Nicholas
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_4rcd9h5ia5cj6h4cpgtlnnbdun